PRKAA2 and familial dilated cardiomyopathy: Another metabolism-related pathway, the AMP-activated protein kinase (AMPK) signalling pathway, was also among the top 10 de-regulated pathways associated with oHCM and was not amongst the top 10 de-regulated pathways for DCM and ISCM.